¾çÇѸ𠱳¼ö, ¹Ì±¹½ÉÀåÇÐȸ ÀþÀº¿¬±¸ÀÚ»ó 5Àο¡ ¼±Á¤

¾çÇѸð/±èÈ¿¼ö ±³¼öÆÀ¡¦Çѱ¹ ¿¬±¸¼öÁØ ¼¼°è¿¡ ÀÎÁ¤¹Þ¾Æ
´º½ºÀÏÀÚ: 2011³â04¿ù28ÀÏ 00½Ã00ºÐ

¼­¿ï´ëÇб³º´¿ø ¼øȯ±â³»°ú ¾çÇѸ𠱳¼ö(½ÉÇ÷°ü¼¾ÅÍ ±èÈ¿¼ö ±³¼ö ¿¬±¸ÆÀ)´Â ÃÖ±Ù ¹Ì±¹¿¡¼­ °³ÃÖµÈ Á¦60ȸ ¹Ì±¹½ÉÀåÇÐȸ(ACC: American College of Cardiology) ¿¬·ÊȸÀÇ¿¡¼­ ÀþÀº¿¬±¸ÀÚ»ó ÃÖÁ¾ 5ÀÎ (Young Investigator Awardee)¿¡ ¼±Á¤µÆ´Ù.

¹Ì±¹½ÉÀåÇÐȸ´Â ¸Å³â 2-3¸¸¸í Á¤µµ°¡ Âü¿©ÇÏ´Â ±¹Á¦ÇÐȸ·Î À̹ø ÇÐȸ¿¡´Â 1¸¸¿© ÆíÀÌ ³Ñ´Â ÃÊ·Ï°ú ³í¹®ÀÌ Á¢¼öµÇ¾úÀ¸¸ç ÀÌÁß ÃÖÁ¾ 5Æí¿¡ ¼±Á¤µÇ´Â ¿µ¿¹¸¦ ¾È¾Ò´Ù.

 ¾çÇѸ𠱳¼öÀÇ ³í¹®(³í¹®¸í : Paclitaxel Itself Induces Drug-resistance to Paclitaxel in Vascular Smooth Muscle Cells and Reduces Its Effect of Suppression of Neointimal Hyperplasia after Angioplasty)Àº °ü»óµ¿¸ÆÁúȯÀÇ Ä¡·á¿¡ ¸¹ÀÌ ¾²ÀÌ´Â Paclitaxel-Coated StentÀÇ Paclitaxel ¼ººÐÀÌ Ç÷°üÆòÈ°±Ù¼¼Æ÷ÀÇ ÀúÇ×¼ºÀ» À¯µµÇؼ­ ½º½º·ÎÀÇ È¿°ú°¡ °¨¼ÒµÊÀ» ÃÖÃÊ·Î ¹àÇô ¾ÕÀ¸·Î À̸¦ ÀÌ¿ëÇÏ¿© ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈ­ÇÏ°í Ä¡·á È¿°ú¸¦ ±Ø´ëÈ­ ÇÒ ¼ö ÀÖ´Â »õ·Î¿î Àü±â¸¦ ¸¶·ÃÇÑ °ÍÀ¸·Î Æò°¡µÇ°í ÀÖ´Ù.

±¹³»¿¬±¸·Î Çѱ¹ÀÎÀÌ º» ÇÐȸ¿¡¼­ ÃÖÁ¾ 5Àο¡ ¼±Á¤µÇ±â´Â À̹øÀÌ Ã³À½À̾ ¼­¿ï´ëº´¿ø ¼øȯ±â³»°úÀÇ ¿¬±¸¼öÁØÀ» ´Ù½Ã ÇÑ ¹ø Àü¼¼°è¿¡ ³Î¸® ¾Ë¸®°í ÀÎÁ¤¹ÞÀ» ¼ö ÀÖ´Â °è±â°¡ µÈ °ÍÀ¸·Î Æò°¡µÇ°í ÀÖ´Ù.

 

 


ÀÌ ´º½ºÅ¬¸®ÇÎÀº BKT´º½º{www.bktimes.net}¿¡¼­ ¹ßÃéµÈ ³»¿ëÀÔ´Ï´Ù.